Re:How to Build a Biotech
by hobofan on Tuesday July 14, 2020 @12:22AM
(#23828501)
> There are countless brilliant founders in biotech who toiled for 5+ years to only find out their drug which had a credible mechanism of action failed phase 2 clinicals and now isn't worth a damn. In software, founders of this caliber would have since pivoted and more than likely created a product of some value.
That sounds like it's specific to pharma-biotech. In non-pharma biotech there seems to be more freedom to pivot (e.g. this story[0] from a few days ago).
That sounds like it's specific to pharma-biotech. In non-pharma biotech there seems to be more freedom to pivot (e.g. this story[0] from a few days ago).
[0]: https://news.ycombinator.com/item?id=23749296